Search research articles
Contact Us
Filters
Showing results (311-320 of 339) with videos related to
Page
of 34
Sort By:
Blood Advances
|
January 26, 2021
Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia
Anjali S Advani, Eric Larsen, Kristina Laumann, et al.
Leukemia & Lymphoma
|
February 28, 2015
Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997
David M Lucas, Amy S Ruppert, Gerard Lozanski, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Prognostic impact of age and MDS-associated mutations in <i>NPM1</i> -mutated AML
Vivian M Liu, Megan Othus, Jasmine Naru, et al.
Blood
|
January 14, 2017
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era
Simon Mantha, Debra A Goldman, Sean M Devlin, et al.
Blood
|
June 27, 2012
Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia
Robert E Gallagher, Barry K Moser, Janis Racevskis, et al.
Biomarker Research
|
August 21, 2020
AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report
Era L Pogosova-Agadjanyan, Anna Moseley, Megan Othus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 26, 2006
Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen
H Joachim Deeg, Barry E Storer, Michael Boeckh, et al.
Blood
|
April 7, 2006
Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction
Carla S Wilson, George S Davidson, Shawn B Martin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 14, 2013
Acute myeloid leukemia, version 2.2013
Margaret R O'Donnell, Martin S Tallman, Camille N Abboud, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 11, 2012
NCCN Clinical Practice Guidelines Acute myeloid leukemia
Margaret R O'Donnell, Camille N Abboud, Jessica Altman, et al.
Page
of 34
Search research articles
Search
Showing results (311-320 of 339) with videos related to
Sort By:
Page
of 34
Blood Advances
|
January 26, 2021
Comparison of CALGB 10403 (Alliance) and COG AALL0232 toxicity results in young adults with acute lymphoblastic leukemia
Anjali S Advani, Eric Larsen, Kristina Laumann, et al.
Leukemia & Lymphoma
|
February 28, 2015
Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997
David M Lucas, Amy S Ruppert, Gerard Lozanski, et al.
Medrxiv : the Preprint Server for Health Sciences
|
November 24, 2025
Prognostic impact of age and MDS-associated mutations in <i>NPM1</i> -mutated AML
Vivian M Liu, Megan Othus, Jasmine Naru, et al.
Blood
|
January 14, 2017
Determinants of fatal bleeding during induction therapy for acute promyelocytic leukemia in the ATRA era
Simon Mantha, Debra A Goldman, Sean M Devlin, et al.
Blood
|
June 27, 2012
Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemia
Robert E Gallagher, Barry K Moser, Janis Racevskis, et al.
Biomarker Research
|
August 21, 2020
AML risk stratification models utilizing ELN-2017 guidelines and additional prognostic factors: a SWOG report
Era L Pogosova-Agadjanyan, Anna Moseley, Megan Othus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 26, 2006
Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen
H Joachim Deeg, Barry E Storer, Michael Boeckh, et al.
Blood
|
April 7, 2006
Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction
Carla S Wilson, George S Davidson, Shawn B Martin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
September 14, 2013
Acute myeloid leukemia, version 2.2013
Margaret R O'Donnell, Martin S Tallman, Camille N Abboud, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 11, 2012
NCCN Clinical Practice Guidelines Acute myeloid leukemia
Margaret R O'Donnell, Camille N Abboud, Jessica Altman, et al.
Page
of 34